Publication | Closed Access

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers

Schizophrenic PatientsPsychoactive DrugPsychiatryPsychotic DisorderPsychotropic MedicationHealthy VolunteersForensic ToxicologyPsychopharmacologySchizophreniaNeuropsychiatryNeuropharmacologyNeuroscienceNeurologyBiological PsychiatryMedicineCerebroventricular SizeSocial Sciences